【Company Research】JOYY Inc. (YY US) – Solid 4Q19; Eyes on overseas momentum

JOYY delivered solid 4Q19 results, with revenue/adj. EPADS +64%/-48.6% YoY, 2%/3% higher than consensus. We keep positive on its overseas expansion, forecasting Bigo to see 60% YoY revenue growth and monthly breakeven in FY20E. We think market concern on COVID-19 and regulation impact has been partly eased by this result. Maintain BUY with unchanged TP of US$74.

 

  • 4Q19 beat. 4Q19 revenue grew 64% YoY, 1%/2% higher than our estimates/ consensus. Adj. EPS declined 48.6% YoY (for Bigo’s consolidation), 0%/3% above our estimate/ consensus. Mgmt. guided 1Q20E revenue at RMB6.75bn-6.85bn (midpoint +42% YoY), in line with consensus. We view this result as positive, on both solid financials and user metrics.

 

  • Overseas expansion to step up. As stated in our preview report, we keep confident on Bigo’s overseas expansion, and mgmt. guided 60% YoY revenue growth in FY20E. Bigo performed well in developed countries (e.g. USA, Japan, Europe), with 31% revenue mix from these regions in 4Q19 (vs. 26% in 3Q19). Its paying users in developed countries surged 50% in Dec (vs. Jun).  Likee would begin monetization in 2020 through livestreaming and ads, forecasting to contribute 10% of Bigo’s revenue. We view Bigo resilient to the epidemic, and kept its net loss forecast of US$150mn in FY20E unchanged. We expect Bigo to achieve monthly breakeven in FY20E, and overall breakeven in FY21E.

 

  • Stable YY Live with limited impact from epidemic and regulation. Given epidemic impact and regulation headwinds, mgmt. guided low single-digit growth for YY Core’s revenue in FY20E. We view this guidance in line with our expectation, and we forecast YY Core’s revenue to grow at 3% YoY in FY20E and decline 5% YoY in 1Q20E, as stated in our preview report. We estimate its non-GAAP OPM at 20% in FY20E and 18% in 1Q20E, mainly on innovative features and initiatives investment.

 

  • Maintain BUY. We maintain our forecast and TP of US$74 unchanged. The stock is now trading at 10x/7x FY20/21E P/E. Valuation is attractive. We think COVID-19 and regulation impact have been priced in. Healthy user metrics trend and overseas expansion could be further catalysts, as investors gradually digested global TAM and competition landscape.
Click to read the report

Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong

Telephone: (852)3900 0888 Fax:(852)3761 8788

Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.